SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth is trending as reports indicate a significant $1.6 billion US government investment, including a 10% equity stake and debt financing, aimed at bolstering domestic critical mineral production. This news has triggered an overnight trading halt and fueled highly bullish community sentiment, with many anticipating a substantial short squeeze and new all-time highs. Investors see this as a strategic 'America First' move in a hot rare earth sector, reinforcing supply chain security.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is surging to unprecedented levels, propelled by reports of a historic physical silver shortage in Asia and ongoing geopolitical uncertainties. The community is fiercely divided, with bulls celebrating massive gains and anticipating further parabolic upside due to short squeezes and systemic shifts, while bears vehemently warn of an unsustainable "blow off top" and an imminent, sharp correction. This extraordinary price action highlights intense speculation surrounding silver's dual role as a critical industrial metal and a hedge against fiat currency debasement.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is hitting unprecedented record highs, fueling intense community discussion on whether this represents a fundamental shift towards safe-haven assets amidst global uncertainty and dollar weakness, or an overheated, speculative frenzy. Sentiment is sharply divided between those expecting continued strength from central bank diversification and others anticipating a significant market correction after such a rapid ascent.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Thompson Falls, MT.

United States Antimony Corp.

United States Antimony Corp

United States Antimony (UAMY) is generating significant buzz following its acquisition of a fully operational critical minerals flotation facility, strengthening its processing capabilities for antimony and other strategic materials. The community is highly bullish, anticipating further government investments to secure domestic supply chains, especially given the State of Alaska's recent share purchase and broader geopolitical focus on critical minerals.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending, driven by immediate clarity from its CEO regarding positive Glioblastoma trial data, which showed median overall survival was not yet reached as patients live longer than expected. The community is buzzing about forthcoming updates on its HPV vaccine and a potential massive short squeeze, fueled by high short interest and a significantly reduced public float following strategic debt conversions. This innovative "chemo-free" immunotherapy platform, bolstered by recent global partnerships including Saudi approvals, is seen as a major disruptor in oncology.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. is experiencing a significant short squeeze, fueled by a recent AI-related deal and an extremely low float. The community is actively debating its parabolic run, with many anticipating continued upward momentum reminiscent of past volatile stock surges, while others warn of extreme volatility and potential risks. This explosive price action has drawn broad attention, especially given the current interest in AI sector plays.

HashPack is the leading retail wallet on Hedera Hashgraph with a fantastic user experience for defi, NFTs and dApps. The wallet is non-custodial, audited and features free email account creation as well as seed phrase based account creation. HashPack is integrated with every major dApp in the Hedera Hashgraph ecosystem and is deeply involved in the retail and developer communities.

HashPack

PACK (HashPack) is trending due to its recent recognition as an official Hedera Council Community Partner, solidifying its influence within the ecosystem. The community is actively discussing crucial integrations like WalletConnect and various fiat on-ramps, alongside a new token buyback program designed to enhance utility and user rewards. These advancements are seen as strengthening HashPack's role as a primary gateway for DeFi and NFT activity within the Hedera network.

Freeport-McMoRan, Inc. engages in the mining of copper, gold, and molybdenum. It operates through the following segments: North America Copper Mines, South America Operations, Indonesia Operations, Molybdenum Mines, Rod and Refining, Atlantic Copper Smelting and Refining, and Corporate and Other. The North America Copper Mines segment operates open-pit copper mines in Morenci, Bagdad, Safford, Sierrita, Miami in Arizona and Chino, and Tyrone in New Mexico. The South America Operations segment includes Cerro Verde in Peru and El Abra in Chile. The Indonesia Operations segment handles the operations of the Grasberg minerals district that produce copper concentrate containing significant quantities of gold and silver. The Molybdenum Mines segment includes the Henderson underground mine and Climax open pit mine, both in Colorado. The Rod and Refining segment consists of copper conversion facilities located in North America and includes a refinery and rod mills. The Atlantic Copper Smelting and Refining segment smelts and refines copper concentrate and markets refined copper and precious metals in slimes. The Corporate and Other segment offers other mining and eliminations, oil and gas operations, and other corporate and elimination items. The company was founded by James R. Moffett on November 10, 1987, and is headquartered in Phoenix, AZ.

Freeport-McMoRan Inc

Freeport-McMoRan is trending amidst its strong earnings and updated guidance, which are reassuring investors despite past production challenges at its Grasberg mine, now slated for a phased restart. Community discussions highlight record-high copper prices and a growing conviction around a structural supply deficit driven by insatiable demand from electrification, AI, and data centers. This positions FCX as a pivotal asset in the critical minerals landscape.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

Revolution Medicines faces market volatility following reports that acquisition talks with a major pharmaceutical company concluded without an agreement on price. Despite the immediate reaction, investors are actively debating the long-term value of RVMD's promising oncology pipeline for RAS-addicted cancers, with many speculating about potential interest from other suitors in a competitive biotech M&A environment.

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Enanta Pharmaceuticals Inc

Enanta Pharmaceuticals is trending after announcing positive topline results from its Phase 2b study of zelicapavir for RSV, highlighting significant antiviral activity and symptom improvement, despite missing the primary endpoint. This news, coupled with recent analyst upgrades, contrasts with community concerns regarding a dilutive public offering, sparking intense debate over the company's valuation and future prospects in the competitive RSV antiviral landscape.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Preferred Bank (PFBC) Surpasses Q4 Earnings and Revenue Estimates

Preferred Bank (PFBC) delivered earnings and revenue surprises of +0.45% and +2.32%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Sierra Bancorp (BSRR) Projected to Post Earnings on Monday

Sierra Bancorp (NASDAQ:BSRR) will be releasing its Q4 2025 earnings before the market opens on Monday, January 26. (View Earnings Report at...

Sierra Bancorp (NASDAQ:BSRR) Director Sells $175,000.00 in Stock

Sierra Bancorp (NASDAQ:BSRR - Get Free Report) Director Lynda Scearcy sold 5,000 shares of the company's stock in a transaction on Thursday, January 15th. The shares were sold at an average price of...

Sierra Bancorp (NASDAQ:BSRR) Share Price Crosses Above 200-Day Moving Average - Here's Why

Sierra Bancorp (NASDAQ:BSRR) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened...

Sierra Bancorp (NASDAQ:BSRR) Shares Cross Above 200-Day Moving Average - Here's What Happened

Sierra Bancorp (NASDAQ:BSRR) Stock Price Passes Above 200-Day Moving Average - Time to Sell...

Sierra Bancorp (NASDAQ:BSRR) Stock Passes Above 200 Day Moving Average - Time to Sell?

Sierra Bancorp (NASDAQ:BSRR) Stock Passes Above 200-Day Moving Average - Time to Sell...

Susan Abundis Sells 600 Shares of Sierra Bancorp (NASDAQ:BSRR) Stock

Sierra Bancorp (NASDAQ:BSRR - Get Free Report) Director Susan Abundis sold 600 shares of the stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $33.50...

American Century Companies Inc. Increases Holdings in Sierra Bancorp $BSRR

American Century Companies Inc. lifted its stake in Sierra Bancorp (NASDAQ:BSRR - Free Report) by 35.3% during the second quarter, according to its most recent 13F filing with the Securities and...

Insider Selling: Sierra Bancorp (NASDAQ:BSRR) CAO Sells 3,443 Shares of Stock

Sierra Bancorp (NASDAQ:BSRR - Get Free Report) CAO Cindy Dabney sold 3,443 shares of the company's stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average...

Sierra Bancorp (NASDAQ:BSRR) CAO Cindy Dabney Sells 3,443 Shares

Sierra Bancorp (NASDAQ:BSRR - Get Free Report) CAO Cindy Dabney sold 3,443 shares of the business's stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of...

Sierra Bancorp is a holding company, which engages in the business of holding the stock of the Bank of the Sierra and its subsidiaries. The firm is also involved in the provision of specialized lending services through a dedicated agricultural credit office. Its loan portfolio includes agricultural, commercial, consumer, real estate, construction, and mortgage. The company was founded by James C. Holly in 1978 and is headquartered in Porterville, CA.

Sierra Bancorp

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

BSRR
Sierra Bancorp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest BSRR News

BSRRSierra Bancorp